We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

Back to rankings

3 hedge funds and large institutions have $21K invested in Sucampo Pharmaceuticals, Inc. in 2018 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 183 closing their positions.

New
Increased
Maintained
Reduced
Closed

98% less funds holding

Funds holding: 188 → 3 (-185)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $645M → $21K (-$645M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 183

Holders
3
Holders Change
-185
Holders Change %
-98.4%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
183
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$73.1M
2
LSV Asset Management
LSV Asset Management
Illinois
-$44.4M
3
Renaissance Technologies
Renaissance Technologies
New York
-$35.1M
4
PC
Paulson & Co
New York
-$28.7M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$27.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
BPM
51
Bowling Portfolio Management
Ohio
– -$2.98M -166,088 Closed
GCIA
52
Gabelli & Co Investment Advisers
New York
– -$2.98M -165,900 Closed
WIC
53
Water Island Capital
New York
– -$2.69M -150,000 Closed
Ohio Public Employees Retirement System (OPERS)
54
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$2.67M -148,799 Closed
OAC
55
OMERS Administration Corp
Ontario, Canada
– -$2.21M -123,300 Closed
Barclays
56
Barclays
United Kingdom
– -$2.04M -113,490 Closed
PPA
57
Parametric Portfolio Associates
Washington
– -$2.01M -112,074 Closed
QI
58
QS Investors
New York
– -$1.95M -108,513 Closed
ECM
59
ETrade Capital Management
Virginia
– -$1.86M -103,875 Closed
AIM
60
Alambic Investment Management
California
– -$1.83M -101,800 Closed
Bank of Montreal
61
Bank of Montreal
Ontario, Canada
– -$1.82M -101,466 Closed
GC
62
Globeflex Capital
California
– -$1.82M -101,190 Closed
HA
63
Havens Advisors
New York
– -$1.79M -100,000 Closed
WRBC
64
W.R. Berkley Corp
Connecticut
– -$1.78M -99,028 Closed
AA
65
AlphaMark Advisors
Kentucky
– -$1.69M -93,928 Closed
TCIM
66
TIAA CREF Investment Management
New York
– -$1.59M -88,464 Closed
TIAAOA
67
Teachers Insurance & Annuity Association of America
New York
– -$1.58M -87,816 Closed
MCC
68
Malaga Cove Capital
California
– -$1.52M -84,747 Closed
N
69
Nuveen
North Carolina
– -$1.5M -83,542 Closed
CCM
70
Cadence Capital Management
Massachusetts
– -$1.49M -83,021 Closed
BGIM
71
Brandywine Global Investment Management
Pennsylvania
– -$1.4M -78,107 Closed
O
72
OppenheimerFunds
New York
– -$1.39M -77,292 Closed
Wells Fargo
73
Wells Fargo
California
– -$1.37M -76,270 Closed
AllianceBernstein
74
AllianceBernstein
Tennessee
– -$1.35M -75,407 Closed
New York State Common Retirement Fund
75
New York State Common Retirement Fund
New York
– -$1.33M -73,932 Closed
1 2
3
4 5

SCMP Hedge Fund Activity: Q1 2018 in Review

3 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q1 2018, worth a combined $21K — down 100% from $645M a quarter earlier.

Sellers outnumbered buyers: 183 funds closed out of SCMP and 0 opened new positions — a net loss of 183 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $73.1M sold.

  • 3 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q1 2018, down from 188 in Q4 2017.
  • Funds reported $21K of Sucampo Pharmaceuticals, Inc. stock for Q1 2018, down 100% quarter-over-quarter.
  • 0 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q1 2018 and 183 closed out, a net change of -183 holders.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q1 2018 was BlackRock, an estimated $73.1M sold.

Based on aggregated 13F filings for Q1 2018.